We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-1.34%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.17B
AUM Growth
+$393M
Cap. Flow
+$459M
Cap. Flow %
39.32%
Top 10 Hldgs %
24.34%
Holding
4,355
New
842
Increased
1,505
Reduced
871
Closed
1,089

Sector Composition

Rank Sector Weight
1 Financials 6.75%
2 Industrials 5.87%
3 Consumer Discretionary 5.39%
4 Technology 4.75%
5 Healthcare 3.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OEF icon
2401
iShares S&P 100 ETF
OEF
$20.5B
$12K ﹤0.01%
+100
New +$12.1K
QMCO icon
2402
Quantum Corp
QMCO
$464M
$12K ﹤0.01%
171
-402
-70% -$39.1K
RCKT icon
2403
Rocket Pharmaceuticals
RCKT
$397M
$12K ﹤0.01%
+652
New +$10.6K
VTWV icon
2404
Vanguard Russell 2000 Value ETF
VTWV
$1.36B
$12K ﹤0.01%
+109
New +$11.9K
VBIV
2405
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$12K ﹤0.01%
117
+97
+485% +$11.6K
NM
2406
DELISTED
Navios Maritime Holdings Inc.
NM
$12K ﹤0.01%
1,353
-235
-15% -$2.91K
KLR
2407
DELISTED
Kaleyra, Inc.
KLR
$12K ﹤0.01%
+344
New +$11.7K
XELA
2408
DELISTED
Exela Technologies, Inc. Common Stock
XELA
0
RBNC
2409
DELISTED
Reliant Bancorp, Inc. Common Stock
RBNC
$12K ﹤0.01%
525
+148
+39% +$3.62K
ALSK
2410
DELISTED
Alaska Communications Systems
ALSK
$12K ﹤0.01%
+6,706
New +$15.1K
CEL
2411
DELISTED
Cellcom Israel, Ltd.
CEL
$12K ﹤0.01%
1,746
+338
+24% +$2.92K
GV
2412
DELISTED
Goldfield Corporation
GV
$12K ﹤0.01%
3,056
+1,036
+51% +$4.91K
LBY
2413
DELISTED
Libbey, Inc.
LBY
$12K ﹤0.01%
+2,544
New +$17.3K
MSF
2414
DELISTED
Morgan Stanley Emerging Mkts Fd
MSF
$12K ﹤0.01%
627
-862
-58% -$16.2K
XPLR
2415
DELISTED
Xplore Technologies Corp.
XPLR
$12K ﹤0.01%
+3,772
New +$11.6K
CMO
2416
DELISTED
Capstead Mortgage Corp.
CMO
$12K ﹤0.01%
1,400
+700
+100% +$6.06K
CEO
2417
DELISTED
CNOOC Limited
CEO
$12K ﹤0.01%
80
-320
-80% -$48.1K
AMED
2418
DELISTED
Amedisys
AMED
$11K ﹤0.01%
+189
New +$10.8K
BILI icon
2419
Bilibili
BILI
$7.95B
$11K ﹤0.01%
+963
New +$10.7K
BRID icon
2420
Bridgford Foods
BRID
$57.8M
$11K ﹤0.01%
+720
New +$12.1K
BZQ icon
2421
ProShares UltraShort MSCI Brazil Capped
BZQ
$2.52M
$11K ﹤0.01%
+20
New +$11.7K
CBU icon
2422
Community Bank
CBU
$3.37B
$11K ﹤0.01%
+200
New +$10.9K
CHRW icon
2423
C.H. Robinson
CHRW
$17.3B
$11K ﹤0.01%
122
-67
-35% -$6.17K
CIVB icon
2424
Civista Bancshares
CIVB
$585M
$11K ﹤0.01%
476
-3,640
-88% -$81.7K
DRRX
2425
DELISTED
DURECT Corp
DRRX
$11K ﹤0.01%
510
-1,539
-75% -$21.5K

Similar funds

Tower Research Capital (TRC)'s Q1 2018 Portfolio in Review

As of Q1 2018, Tower Research Capital (TRC) held 4,355 positions worth $1.17B, up 51% from $775M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Tower Research Capital (TRC) deployed $459M of net new capital in Q1 2018, opening 842 new positions and adding to 1,505 existing holdings. Its largest new stake was iShares MSCI EAFE ETF: 717,758 shares worth $50M.

By sector, the portfolio is most concentrated in Financials at 6.7% of assets, down from 11% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $21M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2018 buy was iShares MSCI EAFE ETF: 717,758 shares worth $50M.
  • Tower Research Capital (TRC) added most to iShares MSCI Emerging Markets ETF in Q1 2018, an estimated $69.7M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $21M.
  • Tower Research Capital (TRC) fully exited Berkshire Hathaway Class B in Q1 2018, selling an estimated $7.94M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 24% of its $1.17B portfolio in Q1 2018.
  • Tower Research Capital (TRC) opened 842 new positions and closed 1,089 in Q1 2018.
  • Tower Research Capital (TRC)'s portfolio value rose 51% quarter-over-quarter to $1.17B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2018, filed 15 May 2018.